333 related articles for article (PubMed ID: 31173289)
1. LncRNA SNHG5 promotes cisplatin resistance in gastric cancer via inhibiting cell apoptosis.
Li M; Zhang YY; Shang J; Xu YD
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4185-4191. PubMed ID: 31173289
[TBL] [Abstract][Full Text] [Related]
2. LncRNA DANCR accelerates the development of multidrug resistance of gastric cancer.
Xu YD; Shang J; Li M; Zhang YY
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2794-2802. PubMed ID: 31002130
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance.
Zhang XW; Bu P; Liu L; Zhang XZ; Li J
Biochem Biophys Res Commun; 2015 Jul; 462(3):227-32. PubMed ID: 25956062
[TBL] [Abstract][Full Text] [Related]
4. LncRNA HMGA1P4 promotes cisplatin-resistance in gastric cancer.
Qiao XL; Zhong ZL; Dong Y; Gao F
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8830-8836. PubMed ID: 32964971
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of long non-coding RNA GHET1 promotes the development of multidrug resistance in gastric cancer cells.
Zhang X; Bo P; Liu L; Zhang X; Li J
Biomed Pharmacother; 2017 Aug; 92():580-585. PubMed ID: 28578256
[TBL] [Abstract][Full Text] [Related]
6. Notch 1 promotes cisplatin-resistant gastric cancer formation by upregulating lncRNA AK022798 expression.
Hang Q; Sun R; Jiang C; Li Y
Anticancer Drugs; 2015 Jul; 26(6):632-40. PubMed ID: 25763542
[TBL] [Abstract][Full Text] [Related]
7. Silencing of long non-coding RNA ANRIL inhibits the development of multidrug resistance in gastric cancer cells.
Lan WG; Xu DH; Xu C; Ding CL; Ning FL; Zhou YL; Ma LB; Liu CM; Han X
Oncol Rep; 2016 Jul; 36(1):263-70. PubMed ID: 27121324
[TBL] [Abstract][Full Text] [Related]
8. LncRNA SNHG6 knockdown inhibits cisplatin resistance and progression of gastric cancer through miR-1297/BCL-2 axis.
Mei J; Liu G; Li R; Xiao P; Yang D; Bai H; Hao Y
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34821362
[TBL] [Abstract][Full Text] [Related]
9. Induction of ferroptosis by ATF3 elevation alleviates cisplatin resistance in gastric cancer by restraining Nrf2/Keap1/xCT signaling.
Fu D; Wang C; Yu L; Yu R
Cell Mol Biol Lett; 2021 Jun; 26(1):26. PubMed ID: 34098867
[TBL] [Abstract][Full Text] [Related]
10. [Molecular mechanism of cisplatin to enhance the ability of TRAIL in reversing multidrug resistance in gastric cancer cells].
Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):404-11. PubMed ID: 26463141
[TBL] [Abstract][Full Text] [Related]
11. TXNL1 induces apoptosis in cisplatin resistant human gastric cancer cell lines.
Ni P; Xu W; Zhang Y; Chen Q; Li A; Wang S; Xu S; Zhou J
Curr Cancer Drug Targets; 2015; 14(9):850-9. PubMed ID: 25348020
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of miRNA-200c on chemotherapy-resistance and cell proliferation of gastric cancer SGC7901/DDP cells.
Chen Y; Zuo J; Liu Y; Gao H; Liu W
Chin J Cancer; 2010 Dec; 29(12):1006-11. PubMed ID: 21114921
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-206 facilitates gastric cancer cell apoptosis and suppresses cisplatin resistance by targeting MAPK2 signaling pathway.
Chen Z; Gao YJ; Hou RZ; Ding DY; Song DF; Wang DY; Feng Y
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):171-180. PubMed ID: 30657558
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
Cheng C; Qin Y; Zhi Q; Wang J; Qin C
Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of CASC2 contributes to cisplatin resistance in gastric cancer by sponging miR-19a.
Li Y; Lv S; Ning H; Li K; Zhou X; Xv H; Wen H
Biomed Pharmacother; 2018 Dec; 108():1775-1782. PubMed ID: 30372881
[TBL] [Abstract][Full Text] [Related]
16. miR-1271 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R, IRS1, mTOR, and BCL2.
Yang M; Shan X; Zhou X; Qiu T; Zhu W; Ding Y; Shu Y; Liu P
Anticancer Agents Med Chem; 2014; 14(6):884-91. PubMed ID: 24875127
[TBL] [Abstract][Full Text] [Related]
17. Reversion of multidrug resistance by SKI-II in SGC7901/DDP cells and exploration of underlying mechanisms.
Zhu ZA; Zhu ZQ; Cai HX; Liu Y
Asian Pac J Cancer Prev; 2012; 13(2):625-31. PubMed ID: 22524836
[TBL] [Abstract][Full Text] [Related]
18. [Ethoxysanguinarine directly targets CIP2A to inhibit proliferation and induce autophagy of SGC7901/DDP cells].
Wan F; Tan M; Xiang YC; Liu XW; Peng P; Liu Y
Zhongguo Zhong Yao Za Zhi; 2022 Nov; 47(21):5890-5899. PubMed ID: 36472008
[TBL] [Abstract][Full Text] [Related]
19. Let-7b attenuates cisplatin resistance and tumor growth in gastric cancer by targeting AURKB.
Han X; Zhang JJ; Han ZQ; Zhang HB; Wang ZA
Cancer Gene Ther; 2018 Dec; 25(11-12):300-308. PubMed ID: 30237418
[TBL] [Abstract][Full Text] [Related]
20. Celastrol Inhibits the Proliferation and Decreases Drug Resistance of Cisplatin- Resistant Gastric Cancer SGC7901/DDP Cells.
Zhan D; Ni T; Wang H; Lv M; Sunagawa M; Liu Y
Anticancer Agents Med Chem; 2022; 22(2):270-279. PubMed ID: 34053427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
